Milestone Pharmaceuticals Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
MIST Nasdaq 2830 www.milestonepharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Submits Response to the FDA’s CRL for CARDAMYST (etripamil) Nasal Spray for PSVT Following Type A Meeting - Jun 16th, 2025 6:00 am
Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - May 28th, 2025 6:00 am
Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's Why - May 22nd, 2025 10:00 am
Milestone Pharmaceuticals: Q1 Earnings Snapshot - May 14th, 2025 5:22 am
Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update - May 14th, 2025 5:04 am
MIST Stock Falls 66% Following Complete Response Letter for Cardamyst - Apr 2nd, 2025 1:00 pm
Milestone Pharmaceuticals downgraded to Hold from Buy at TD Cowen - Apr 2nd, 2025 6:37 am
TD downgrades Milestone Pharmaceuticals, suspends target on Etripamil uncertainty - Apr 1st, 2025 1:48 pm
Milestone CRL affirms integrity of clinical data, says H.C. Wainwright - Mar 29th, 2025 10:00 am
FDA Issues Complete Response Letter for Etripamil for PSVT - Mar 28th, 2025 5:00 am
Milestone Pharmaceuticals to Present Clinical Data on Etripamil at the American College of Cardiology - Mar 20th, 2025 6:00 am
Milestone Pharmaceuticals: Q4 Earnings Snapshot - Mar 13th, 2025 5:32 am
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update - Mar 13th, 2025 5:08 am
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Mar 4th, 2025 6:00 am
Milestone® Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference - Feb 27th, 2025 6:00 am
Milestone Pharmaceuticals Gets Notice of Allowance for US Patent on Etripamil Nasal Spray - Feb 19th, 2025 8:13 am
Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil - Feb 19th, 2025 6:00 am
Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025 - Feb 11th, 2025 6:00 am
Loss-Making Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Expected To Breakeven In The Medium-Term - Feb 3rd, 2025 7:59 am
Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC - Jan 28th, 2025 6:00 am